BIOCON
Back to Income Statement
|
BIOCON Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹11,174 Cr | ₹8,184 Cr | ₹7,143 Cr | ₹6,301 Cr | ₹5,514 Cr |
What is the latest Revenue of BIOCON ?
Year | Revenue |
---|---|
Mar2024 | ₹11,174 Cr |
Mar2023 | ₹8,184 Cr |
Mar2022 | ₹7,143 Cr |
Mar2021 | ₹6,301 Cr |
Mar2020 | ₹5,514 Cr |
How is Revenue of BIOCON Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹11,174 Cr | 36.54 | |
Mar2023 | ₹8,184 Cr | 14.57 | |
Mar2022 | ₹7,143 Cr | 13.37 | |
Mar2021 | ₹6,301 Cr | 14.26 | |
Mar2020 | ₹5,514 Cr | - |
Compare Revenue of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹49,916.9 Cr | -0.3% | 9.5% | -0.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹400,005.0 Cr | -0.7% | -1.3% | 6.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹185,609.0 Cr | 1.8% | 4.8% | 49.8% | Stock Analytics | |
CIPLA | ₹120,500.0 Cr | -1.1% | -1.3% | -1.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹113,530.0 Cr | 0.6% | 4.2% | 15.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,954.0 Cr | -1.8% | -6% | -1.6% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -0.3% |
9.5% |
-0.4% |
SENSEX | 0.2% |
1.3% |
4.4% |
You may also like the below Video Courses